This is the second of a two-part summary of a National Institutes of Health conference on
fecal incontinence (FI) that summarizes current treatments and identifies research priorities …

Artificial sphincters (ASs) are used to replace the function of the biological sphincters in case
of severe urinary and fecal incontinence (UI and FI), and gastroesophageal reflux disease …

METHODS An organized search of MEDLINE, PubMed, EMBASE, and the Cochrane
Database of Collected Reviews was performed through March 2014. Key word …

The severity of fecal incontinence widely varies and can have dramatic devastating impacts
on a person's life. Fecal incontinence is common, though it is often under-reported by …

Faecal incontinence, defined as the involuntary loss of solid or liquid stool, is a common
problem affecting 0.8–8.3% of the adult population. Individuals suffering from faecal …

Regenerative medicine (RM) is changing how we think and practice transplant medicine. In
regenerative medicine, the aim is to develop and employ methods to regenerate, restore or …

The purpose of this clinical practice update expert review is to describe the key principles in
the use of surgical interventions and device-aided therapy for managing fecal incontinence …

Background Injectable bulking treatment for fecal incontinence (FI) is intended to expand
tissue in the anal canal and prevent fecal leakage. Use of injectable bulking agents is …

Fecal incontinence (FI) is a multifactorial disorder that imposes considerable social and
economic burdens. The aim of this article is to provide an overview of current and emerging …

BACKGROUND: No systematic review has examined the collective randomized and
nonrandomized evidence for fecal incontinence treatment effectiveness across the range of …